Bafna Pharmaceuticals Ltd
BAFNAPHARM

33.10

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)

33.45

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote
Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
AGM 28-Sep-2016 02-Sep-2016 - -
AGM:28.09.2016
AGM 29-Sep-2015 10-Sep-2015 - -
AGM:29.09.2015 Bafna Pharmaceuticals Ltd has informed BSE that the 20th Annual General Meeting (AGM) of the Company was held on September 29, 2015. (As Per BSE Announcement Dated on 01.10.2015) Bafna Pharmaceuticals Ltd has submitted to BSE a copy of the minutes of the proceedings of the 20th Annual General Meeting (AGM) of the Company held on September 29, 2015. l. Adoption of Financial Statements: To receive, consider and adopt the Balance Sheet as at March 31, 2015 and Statement of Profit and Loss for the year ended on that date, the Reports of Directors and Auditors thereon. 2. Appointment of Director : To appoint a Director in place of Shri Bafna Mahaveer Chand having directors identification number 01458211, who retires by rotation and being eligible, offers himself for re-appointment as Director. 3. Appointment of Director: To appoint a Director in place of Shri Paras Bafna having directors identification Number01933663, who retires by rotation and being eligible, offers himself for re¬appointment as Director. The Chairman declared the resolution having passed as 4. Ratification of Appointment of Statutory Auditor. 5. Appointment of Director - Appointment of Smt. K. Sabitha as a Director . 6. Re-appointment of Shri Bafna Mahaveer Chand as Chairman & Managing Director and revision of remuneration for a period of Two years w.e.f. 01.10.2015. 7. Re-appointment of Shri Paras Bafna as Whole-Time Director and revision of remuneration for a period of Two years w.e.f. 01.10.2015. 8. To ratify Cost Auditors Remuneration. (As Per BSE Announcement Dated on 20.11.2015)